Presentation

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Presenter: Ramin Ebrahimi

October 31, 2016

REGISTER for free or LOG IN to view this content

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Coronary

Presentation

TCT 2016

CAD Pharma

Up Next

Presentation

TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials

Presenter: Bjorn Redfors

October 31, 2016

More slides +

Presentation

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Patrick T. O'Gara

October 31, 2016

Presentation

B Braun - ISAR Coroflex

Presenter: Christian Hengstenberg

October 31, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.